Voriconazole in the Treatment of Invasive Aspergillosis in Kidney Transplant Recipients

Transplantation Proceedings

Volumn 39, Issue 6, 2007, Pages 1838-1840

  Veroux, M ^a   Corona, D ^a   Gagliano, M ^a   Sorbello, M ^a   Macarone, M ^a   Cutuli, M ^a   Giuffrida, G ^a   Morello, G ^a   Paratore, A ^a   Veroux, P ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CASPOFUNGIN; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; VORICONAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LABORATORY DIAGNOSIS; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CADAVER; DRUG THERAPY, COMBINATION; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; PEPTIDES, CYCLIC; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 34547587457     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.05.012     Document Type: Article

References (20)

1. Sia I.G., and Paya C.V. Infectious complications following renal transplantation. Surg Clin North Am 78 (1998) 96
2. Herzog C.A., Ma J.Z., and Collins A.J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339 (1998) 799
3. Schmidt A., and Oberbauer R. Bacterial and fungal infections after kidney transplantation. Curr Opin Urol 9 (1999) 45
4. Abbott K.C., Hypolite I., Poropatich R.K., et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 3 (2001) 203
5. Veroux M., Macarone M., Fiamingo P., et al. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. Transplant Proc 38 (2006) 1037
6. Gupta K.L., Ghosh A.K., Kochhar R., et al. Esophageal candidiasis after renal transplantation: comparative study in patients under different immunosuppressive protocols. Am J Gastroenterol 89 (1994) 1062
7. Chugh K.S., Sakhuja V., Jain S., et al. High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant 8 (1993) 168
8. Weiland D., Ferguson R.M., Peterson P.K., et al. Aspergillosis in 25 renal transplant patients: epidemiology, clinical presentation, diagnosis and management. Ann Surg 198 (1983) 622
9. Lin S.-J., Schranz J., and Teutsch S.M. Aspergillosis case-fatality:systematic review of the literature. Clin Infect Dis 32 (2001) 358
10. Paterson D.L., and Singh N. Invasive aspergillosis in transplant recipients. Medicine 78 (1999) 123
11. Herbrecth R., Denning D.W., Patterson T.F., et al. Invasive fungal infections group of the European organization for research and treatment of cancer and the Global Aspergillus Study group. N Engl J Med 347 (2002) 408
12. Kuypers D.R., Claes K., Evenepoel P., et al. Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. Transplantation 81 (2006) 1750
13. Tintillier M., Kirch L., Goffin E., et al. Interaction between voriconazole and tacrolimus in a kidney-transplanted patient. Nephrol Dial Transplant 20 (2005) 664
14. Schelenz S., and Goldsmith D.J. Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients. J Infect 47 (2003) 336
15. Denning D.W., Ribaud P., Milpied N., et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34 (2002) 563
16. Fortun J., Martin-Davila P., Sanchez M.A., et al. Voriconazole in the treatment of invasive mold infection in transplant recipients. Eur J Clin Microbiol Infect Dis 22 (2003) 408
17. Tintiller M., Kirch L., Goffin E., et al. Interaction between voriconazole and tacrolimus in a kidney-transplanted patient. Nephrol Dial Transplant 20 (2005) 664
18. Rao N.A., and Hidayat A.A. Endogeneous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Ophthalmol 132 (2001) 244
19. Maertens J., Glasmacher A., Herbrecht R., et al. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 107 (2006) 2888
20. Singh N., Limaye A.P., Forrest G., et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 81 (2006) 320